S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
ASML’s Earnings Could Bring The Stock to New Highs
Kinder Morgan Stock Bid Up In An Oil Breakout
Undervalued UnitedHealth Group Won’t Be For Long
3 Computer Vision Stocks for Long-Term Gains From AI
DocuSign and The Case for 66% Upside 
Closing prices for crude oil, gold and other commodities
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
ASML’s Earnings Could Bring The Stock to New Highs
Kinder Morgan Stock Bid Up In An Oil Breakout
Undervalued UnitedHealth Group Won’t Be For Long
3 Computer Vision Stocks for Long-Term Gains From AI
DocuSign and The Case for 66% Upside 
Closing prices for crude oil, gold and other commodities
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
ASML’s Earnings Could Bring The Stock to New Highs
Kinder Morgan Stock Bid Up In An Oil Breakout
Undervalued UnitedHealth Group Won’t Be For Long
3 Computer Vision Stocks for Long-Term Gains From AI
DocuSign and The Case for 66% Upside 
Closing prices for crude oil, gold and other commodities
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
ASML’s Earnings Could Bring The Stock to New Highs
Kinder Morgan Stock Bid Up In An Oil Breakout
Undervalued UnitedHealth Group Won’t Be For Long
3 Computer Vision Stocks for Long-Term Gains From AI
DocuSign and The Case for 66% Upside 
Closing prices for crude oil, gold and other commodities

MariMed (MRMD) Earnings Date, Estimates & Call Transcripts

$0.27
+0.01 (+3.83%)
(As of 04/16/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

MRMD Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MRMD Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

MariMed Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20241($0.01)($0.01)($0.01) 
Q2 20241($0.01)($0.01)($0.01) 
Q3 20241$0.00$0.00$0.00 
Q4 20241$0.00$0.00$0.00 
FY 20244($0.02)($0.02) ($0.02)

MariMed Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/8/2023Q3 2023-($0.01)($0.01)($0.01)$38.70 million$38.80 million    
3/1/2023Q4 2022-$0.01+$0.01$0.01$35.20 million$35.83 million
11/7/2022Q3 2022$0.01$0.01-$0.01$34.20 million$33.91 million
5/10/2022Q1 2022$0.01$0.01-$0.01$30.00 million$31.28 million
3/16/2022Q4 2021$0.02($0.02)($0.04)($0.02)$30.40 million$31.04 million
11/15/2021Q3 2021-$0.01+$0.01$0.01-$33.21 million
8/16/2021Q2 2021-$0.02+$0.02$0.02-$32.57 million

MariMed Earnings - Frequently Asked Questions

How much revenue does MariMed generate each year?

MariMed (OTCMKTS:MRMD) has a recorded annual revenue of $148.60 million.

How much profit does MariMed generate each year?

MariMed (OTCMKTS:MRMD) has a recorded net income of -$16.03 million. MRMD has generated -$0.04 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

This page (OTCMKTS:MRMD) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners